Bifidobacterium in the treatment of inflammatory disease
US7195906B2 · kind B2 · utility
44Cited by
12References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 23, 2004 |
| Grant date | Mar 27, 2007 |
| Priority date | — |
| Expiry date | Feb 23, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/853
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatroy activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.